J. Roblero

708 total citations
40 papers, 487 citations indexed

About

J. Roblero is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J. Roblero has authored 40 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J. Roblero's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (25 papers), Electrolyte and hormonal disorders (11 papers) and Hormonal Regulation and Hypertension (8 papers). J. Roblero is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (25 papers), Electrolyte and hormonal disorders (11 papers) and Hormonal Regulation and Hypertension (8 papers). J. Roblero collaborates with scholars based in Chile, United States and Tanzania. J. Roblero's co-authors include James W. Ryan, H. Croxatto, John M. Stewart, Jenny Corthorn, R. García, Mauricio P. Borić, Eduardo Luis De Vito, John Morrow Stewart, J. Pablo Huidobro‐Toro and Sofía P. Salas and has published in prestigious journals such as CHEST Journal, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

J. Roblero

40 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Roblero Chile 13 236 173 104 102 70 40 487
H. Croxatto Chile 12 236 1.0× 92 0.5× 118 1.1× 111 1.1× 15 0.2× 76 492
L K Kwong United States 12 63 0.3× 209 1.2× 93 0.9× 33 0.3× 19 0.3× 19 568
Margittá Albinus Germany 14 31 0.1× 251 1.5× 40 0.4× 30 0.3× 113 1.6× 40 507
Michael S. LaPointe United States 11 40 0.2× 257 1.5× 224 2.2× 36 0.4× 35 0.5× 14 513
T. Viganò Italy 15 45 0.2× 137 0.8× 45 0.4× 155 1.5× 91 1.3× 41 626
E.P. Dawson United States 8 33 0.1× 127 0.7× 94 0.9× 173 1.7× 23 0.3× 9 430
Barbara A. Weaver United States 11 29 0.1× 280 1.6× 254 2.4× 26 0.3× 128 1.8× 14 600
Mark C. Chappell United States 12 99 0.4× 279 1.6× 634 6.1× 29 0.3× 86 1.2× 13 820
R Beckmann Germany 10 36 0.2× 179 1.0× 49 0.5× 16 0.2× 38 0.5× 86 349
Georgina M. Nemecek United States 9 16 0.1× 184 1.1× 76 0.7× 36 0.4× 64 0.9× 12 398

Countries citing papers authored by J. Roblero

Since Specialization
Citations

This map shows the geographic impact of J. Roblero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Roblero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Roblero more than expected).

Fields of papers citing papers by J. Roblero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Roblero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Roblero. The network helps show where J. Roblero may publish in the future.

Co-authorship network of co-authors of J. Roblero

This figure shows the co-authorship network connecting the top 25 collaborators of J. Roblero. A scholar is included among the top collaborators of J. Roblero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Roblero. J. Roblero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Valencia‐Flores, Matilde, Victoria Santiago-Ayala, Alicia Orea, et al.. (2004). Prevalence of pulmonary hypertension and its association with respiratory disturbances in obese patients living at moderately high altitude. International Journal of Obesity. 28(9). 1174–1180. 27 indexed citations
2.
Croxatto, H., Xavier F. Figueroa, J. Roblero, & Mauricio P. Borić. (1999). Kinin B2 Receptors Mediate Blockade of Atrial Natriuretic Peptide Natriuresis Induced by Glucose or Feeding in Fasted Rats. Hypertension. 34(4). 826–831. 2 indexed citations
3.
Borić, Mauricio P., et al.. (1998). Kinins mediate the inhibition of atrial natriuretic peptide diuretic effect induced by pepsanurin.. PubMed. 31(1). 33–48. 2 indexed citations
4.
Borić, Mauricio P., et al.. (1998). Interactions between bradykinin and ANP in rat kidney in vitro: inhibition of natriuresis and modulation of medullary cyclic GMP.. PubMed. 31(3). 281–9. 4 indexed citations
5.
Croxatto, H., et al.. (1998). [Glucose in conjunction with peptides derived from kininogens might act from digestive tract as blockers of atrial natriuretic peptide mediated diuresis-natriuresis].. PubMed. 126(1). 88–95. 2 indexed citations
6.
Croxatto, H., et al.. (1997). A Peptide Released by Pepsin From Kininogen Domain 1 Is a Potent Blocker of ANP-Mediated Diuresis-Natriuresis in the Rat. Hypertension. 30(4). 897–904. 4 indexed citations
7.
Croxatto, H., et al.. (1996). A Fragment of Human Kininogen Containing Bradykinin Blunts the Diuretic Effect of Atrial Natriuretic Peptide. Experimental Biology and Medicine. 212(2). 128–134. 3 indexed citations
8.
Croxatto, H., et al.. (1993). Blunting Effect of Pepsanurin Introduced in the Duodenum on the Atrial Natriuretic Peptide Diuretic Action in Rats. Experimental Biology and Medicine. 202(3). 371–376. 1 indexed citations
9.
Salas, Sofía P., et al.. (1992). [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.. Journal of Pharmacology and Experimental Therapeutics. 262(3). 979–986. 19 indexed citations
10.
Salas, Sofía P., et al.. (1989). Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.. Journal of Pharmacology and Experimental Therapeutics. 250(3). 992–999. 24 indexed citations
11.
Croxatto, H., et al.. (1986). Effect of amiloride on urinary and renal kallikrein in the rat. American Journal of Physiology-Renal Physiology. 250(3). F400–F406. 4 indexed citations
12.
Roblero, J., et al.. (1976). Release of renal kallikrein to the perfusate by isolated rat kidney. Cellular and Molecular Life Sciences. 32(11). 1440–1441. 10 indexed citations
13.
Croxatto, H., et al.. (1976). Effect of water sodium overloading and diuretics upon urinary kallikrein. Inflammation Research. 6(4). 420–420. 2 indexed citations
14.
Prado, J. L., et al.. (1975). Recovery and conversion of kinins in exsanguinated rat preparations. Naunyn-Schmiedeberg s Archives of Pharmacology. 290(2-3). 191–205. 10 indexed citations
15.
Roblero, J., et al.. (1974). Renal kallikrein (kininogenase activity) in hypertensive rats.. PubMed. 24(5). 439–42. 6 indexed citations
16.
Roblero, J., H. Croxatto, R. García, & Jenny Corthorn. (1974). Kininogenase in urine produced by isolated perfused rat kidneys. Cellular and Molecular Life Sciences. 30(7). 771–772. 4 indexed citations
17.
Roblero, J., Jason Ryan, & John M. Stewart. (1973). Assay of kinins by their effects on blood pressure.. PubMed. 6(1). 206–12. 24 indexed citations
18.
Croxatto, H., et al.. (1973). Effect of furosemide upon urinary kallikrein excretion. Inflammation Research. 3(5). 267–274. 20 indexed citations
19.
Ryan, James W., J. Roblero, Jennifer M. Stewart, & W P Leary. (1971). Metabolism of Vasoactive Polypeptides in the Pulmonary Circulation. CHEST Journal. 59(5). 8S–9S. 6 indexed citations
20.
Roblero, J. & H. Croxatto. (1968). Vasoactive substances formed in blood serum by incubation.. PubMed. 68(2). 235–42. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Croxatto Breakdown of academic impact, for papers by L K Kwong Breakdown of academic impact, for papers by Margittá Albinus Breakdown of academic impact, for papers by Michael S. LaPointe Breakdown of academic impact, for papers by T. Viganò Breakdown of academic impact, for papers by E.P. Dawson Breakdown of academic impact, for papers by Barbara A. Weaver Breakdown of academic impact, for papers by Mark C. Chappell Breakdown of academic impact, for papers by R Beckmann Breakdown of academic impact, for papers by Georgina M. Nemecek
Rankless by CCL
2026